Clinical Trial Update: Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II) [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial of iduronate-2-sulfatase enzyme replacement therapy for mucopolysaccharidosis II (Hunter syndrome) has completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Ii

Drugs mentioned

• iduronate-2-sulfatase (iduronate-2-sulfatase)

Snippet

Sponsor: Shire | Conditions: Mucopolysaccharidosis II | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-05-13